For the Quarter Ending June 2026
Clopidogrel Prices in APAC
- In India, the Clopidogrel Price Index rose by 14.31% quarter-over-quarter, driven by higher feedstock and energy costs.
- The average Clopidogrel price for the quarter was approximately USD 42304.28/MT, reported by ex-works Ludhiana assessments consolidated.
- Clopidogrel Spot Price tightened as institutional Jan Aushadhi tenders and formulators replenished inventories, reducing prompt merchant availability.
- Clopidogrel Price Forecast remains cautiously firm for near months given persistent intermediate inflation and seasonal procurement cycles.
- Clopidogrel Production Cost Trend shows upward pressure from rising acetyls derivatives and elevated coal-based power tariffs nationwide.
- Clopidogrel Demand Outlook remains robust driven by growing cardiovascular prescriptions and expansion of government procurement networks domestically.
- Clopidogrel Price Index volatility moderated in June as steady plant operations offset feedstock cost increases and logistics.
- Export allocations remained steady, constraining spot volumes and supporting firm ex-works offers across the Ludhiana manufacturing cluster.
Why did the price of Clopidogrel change in June 2026 in APAC?
- Rising feedstock costs, notably 2-chloro-4,5-dimethylpyridine and acetyls-chain, increased conversion expenses for Indian API producers pushing EXW higher.
- Escalating energy tariffs and diesel inflation elevated logistics and utility costs, lengthening lead times for domestic buyers.
- Strong public procurement under Jan Aushadhi and hospital replenishment absorbed supply, tightening prompt availability and supporting prices.
Clopidogrel Prices in North America
- In the USA, the Clopidogrel Price Index increased during Q2 2026, driven by sustained pharmaceutical sector demand and firm import costs.
- The average Clopidogrel price for the quarter remained higher compared with the previous quarter as manufacturers adjusted prices to reflect elevated production expenses.
- Clopidogrel Spot Price strengthened amid steady orders from generic drug producers and healthcare distributors.
- Clopidogrel Production Cost Trend increased due to higher active pharmaceutical ingredient processing costs, logistics expenses, and regulatory compliance requirements.
- Clopidogrel Demand Outlook remained robust as cardiovascular therapies continued to record stable prescription volumes throughout North America.
- The Clopidogrel Price Index reflected healthy downstream demand from manufacturers producing antiplatelet drugs used for heart attack prevention, stroke prevention, peripheral artery disease treatment, and post-coronary stent therapy.
- Clopidogrel Price Forecast suggests near-term firmness, supported by stable healthcare consumption and balanced supply conditions.
- Pharmaceutical distributors maintained regular procurement schedules to ensure uninterrupted supply to hospitals, clinics, and retail pharmacy networks.
Why did the price of Clopidogrel change in June 2026 in North America?
- Strong prescription demand for cardiovascular medications supported the Clopidogrel Price Index.
- Rising manufacturing, compliance, and logistics expenses strengthened the Clopidogrel Production Cost Trend during June 2026.
- Stable inventory levels and consistent procurement activity maintained upward momentum in the Clopidogrel Spot Price.
Clopidogrel Prices in Europe
- In Germany, the Clopidogrel Price Index increased moderately during Q2 2026, supported by steady pharmaceutical demand and firm API procurement costs.
- The average Clopidogrel price for the quarter remained above Q1 levels as suppliers maintained disciplined inventory management and passed through higher manufacturing expenses.
- Clopidogrel Spot Price strengthened amid consistent purchasing activity from generic drug manufacturers and pharmaceutical formulators.
- Clopidogrel Production Cost Trend remained firm due to elevated intermediate costs, quality compliance expenses, and pharmaceutical-grade manufacturing requirements.
- Clopidogrel Demand Outlook remained positive as cardiovascular drug demand continued to grow across hospital, retail pharmacy, and healthcare channels.
- The Clopidogrel Price Index reflected stable procurement activity from manufacturers producing antiplatelet medications used in the prevention of heart attacks, strokes, acute coronary syndrome, and post-stent thrombosis management.
- Clopidogrel Price Forecast indicates near-term firmness, supported by resilient healthcare demand and stable pharmaceutical production schedules.
- Market participants reported balanced supply conditions, though cautious inventory management continued to influence procurement strategies across Europe.
Why did the price of Clopidogrel change in June 2026 in Europe?
- Steady demand from generic pharmaceutical manufacturers supported the Clopidogrel Price Index during June 2026.
- Firm intermediate and compliance-related expenses strengthened the Clopidogrel Production Cost Trend, encouraging suppliers to maintain higher offers.
- Controlled inventories and stable procurement activity supported gains in the Clopidogrel Spot Price across the European market.
For the Quarter Ending March 2026
Clopidogrel Prices in APAC
- In India, the Clopidogrel Price Index fell by 9.74% quarter-over-quarter, reflecting weaker tender restocking demand.
- The average Clopidogrel price for the quarter was approximately USD 37009.43/MT, with steady ex-works inventories.
- Domestic Clopidogrel Spot Price softened as distributors reduced elevated inventories, pressuring ex-factory offers thus materially.
- Clopidogrel Price Forecast points to mild recovery as routine formulation restocking and export enquiries firm.
- Clopidogrel Production Cost Trend remained stable as key starting materials and electricity tariffs were unchanged.
- Clopidogrel Demand Outlook stayed subdued short-term because fiscal-year procurement completed and private hospitals deferred purchases.
- Clopidogrel Price Index weakness persisted despite steady plant operations and normalised solvent availability across clusters.
- Manufacturer competition and tender-margin pressure forced producers to trim offers and prioritise immediate-volume demand fulfillment.
Why did the price of Clopidogrel change in March 2026 in APAC?
- Domestic tender completion and fiscal-year buying reduced immediate procurement volumes, weakening buyer pricing-power.
- Adequate plant inventories and uninterrupted production removed urgency, enabling sellers to concede discounts on volumes.
- Stable feedstock and energy costs prevented inflation, so weaker demand drove price declines.
Clopidogrel Prices in North America
- In North America, the Clopidogrel Price Index declined quarter-over-quarter, reflecting moderated procurement activity and sufficient supply conditions.
- Clopidogrel prices softened during the quarter as wholesalers and group purchasing organizations limited fresh buying amid adequate stock levels.
- Domestic Clopidogrel Spot Price eased as distributors focused on drawing down inventories, placing downward pressure on manufacturer quotations.
- Clopidogrel Price Forecast indicates a gradual firming trend supported by routine restocking cycles and stable downstream demand from healthcare providers.
- Clopidogrel Production Cost Trend remained steady, with limited fluctuations in input costs and relatively stable energy pricing.
- Clopidogrel Demand Outlook remained subdued in the short term due to completed contract cycles and cautious procurement strategies among hospital networks.
- Clopidogrel Price Index continued to face pressure despite consistent production rates and reliable supply chain conditions.
- Competitive supplier landscape and contract-driven pricing mechanisms encouraged manufacturers to adjust offers to maintain volume commitments.
Why did the price of Clopidogrel change in March 2026 in North America?
- Completion of procurement cycles among large healthcare buyers reduced immediate purchasing needs, weakening spot demand.
- Sufficient inventory levels across distribution channels reduced urgency for replenishment, strengthening buyer negotiation power.
- Stable production and input costs limited upward pricing pressure, allowing demand-side softness to drive the overall price decline.
Clopidogrel Prices in Europe
- In Europe, the Clopidogrel Price Index declined quarter-over-quarter, mirroring a softer procurement cycle across key markets.
- Clopidogrel prices trended lower through the quarter as distributor destocking and cautious purchasing behavior weighed on supplier negotiations.
- Domestic Clopidogrel Spot Price softened with wholesalers focusing on inventory optimization, leading to reduced ex-factory realizations.
- Clopidogrel Price Forecast further indicates a gradual stabilization as hospital tenders resume and export inquiries from adjacent regions improve.
- Clopidogrel Production Cost Trend remained largely stable, supported by balanced energy markets and minimal volatility in intermediate inputs.
- Clopidogrel Demand Outlook stayed muted in the near term due to completed public-sector tenders and slower replenishment cycles in private channels.
- Clopidogrel Price Index pressure persisted despite steady production rates and sufficient raw material availability across manufacturing hubs.
- Competitive pricing dynamics and tender-driven contracts compelled manufacturers to adjust offers to secure consistent off-take volumes.
Why did the price of Clopidogrel change in March 2026 in Europe?
- Completion of major healthcare tenders across several countries reduced immediate purchasing requirements, limiting spot demand.
- Elevated inventory levels among distributors and hospital networks decreased urgency for fresh procurement, increasing buyer leverage.
- Stable production costs meant pricing was primarily influenced by demand-side weakness rather than input-driven inflation.
For the Quarter Ending December 2025
Clopidogrel Prices in APAC
- In India, the Clopidogrel Price Index fell by 3.58% quarter-over-quarter, due to softer demand conditions.
- The average Clopidogrel price for the quarter was approximately USD 41001.04/MT, based on EXW volumes.
- Clopidogrel Spot Price tightened as warehouses reached working-minimum inventories, supporting sellers' pricing power, limiting discounts.
- Clopidogrel Price Forecast points to mild near-term firmness driven by hospital procurement and export inquiries.
- Clopidogrel Production Cost Trend shows upward pressure from intermediates and inland freight, offset by energy.
- Clopidogrel Demand Outlook remains constructive with Jan Aushadhi procurements and hospital tender cycles sustaining offtake.
- Export inquiries and port throughput influenced the Clopidogrel Price Index, keeping volatility low, upward bias.
- Major Indian producers operated near nameplate capacity, inventory rotation remained tight, supporting ex-works offers ahead.
Why did the price of Clopidogrel change in December 2025 in APAC?
- Sustained production near capacity and uncongested ports limited surplus, keeping domestic availability constrained versus demand.
- Firm hospital procurement and Jan Aushadhi tenders increased offtake, supporting modest upward pressure on prices.
- Rising inland freight and intermediate costs elevated ex-works manufacturing expenses, prompting producers to raise offers.
Clopidogrel Prices in North America
- Regional price indices moderately declined over the quarter due to cautious procurement and inventory adjustments.
- Spot prices softened as producers fulfilled export commitments and distributors managed stocks conservatively.
- Demand remained steady but cautious, with buyers awaiting clearer signals from hospital and formulary procurement cycles.
- Pharmaceutical distributors balanced inventory levels carefully, limiting aggressive restocking.
- Near-term forecast indicates potential moderate recovery supported by production turnarounds and improving downstream demand.
Why December 2025 Prices Changed
- Inventory positions and subdued offtake led to softer pricing conditions.
- Export/import shifts and logistics costs influenced supply distribution, affecting regional availability.
Clopidogrel Prices in Europe
- Europe’s price index slightly weakened as steady supply met mild contraction in downstream demand.
- Spot prices reflected mixed sentiment, with regional variations between central and southern markets.
- Demand outlook showed cautious optimism, with hospitals and manufacturers planning moderate restocking.
- Tender schedules and healthcare budgets influenced downstream offtake across EU markets.
- Price Forecast & Outlook
- Near-term forecast expects stable to firm pricing, supported by seasonal demand improvements and balanced production schedules.
Why December 2025 Prices Changed
- Steady supply inflows from multiple sources limited upward price pressure.
- Cautious demand and inventory adjustments by formulators tempered aggressive pricing shifts.
For the Quarter Ending September 2025
APAC
• In India, the Clopidogrel Price Index fell by 6.56% quarter-over-quarter, due to oversupply and weak demand.
• The average Clopidogrel price for the quarter was approximately USD 42524.99/MT as reported by spot indications.
• Clopidogrel Spot Price softened during the quarter as aggressive destocking and export offers pressured domestic quotations lower.
• Clopidogrel Production Cost Trend improved with lower feedstock costs, allowing suppliers to offer discounted volumes.
• Clopidogrel Demand Outlook remained cautious as formulation buyers delayed replenishment, limiting absorption of elevated inventories.
• Clopidogrel Price Forecast indicates modest seasonal recovery ahead, supported by maintenance shutdowns and festival-driven buying.
• Clopidogrel Price Index volatility reflected INR depreciation and freight reductions, influencing market sentiment and caution.
• Export demand and production diversions tightened domestic availability, supporting upward pressure on spot and contract prices.
Why did the price of Clopidogrel change in September 2025 in APAC?
• Elevated domestic manufacturing and PLI-driven oversupply created inventory glut, exerting downward pressure on September quotations.
• Reduced downstream purchasing and cautious formulation procurement limited demand, preventing absorption of excess market volumes.
• Lower feedstock costs and improved logistics reduced production and freight expenses, enabling sellers to cut prices strategically.
North America
• Clopidogrel Price Index exhibited a moderate decline quarter-over-quarter, influenced by fluctuating inventory positions and subdued offtake from downstream pharmaceutical formulators.
• Average Clopidogrel Price trended lower during the period, reflecting competitive offers amid cautious procurement across the U.S. and Canadian markets.
• Clopidogrel Spot Price softened as producers prioritized export commitments and local distributors reduced inventories to manage cash flow.
• Clopidogrel Production Cost Trend improved slightly with easing input costs and better plant operating rates, though energy price fluctuations created mixed cost dynamics.
• Clopidogrel Demand Outlook remained steady but cautious, as buyers awaited clearer signals from prescription drug demand and hospital purchasing cycles.
• Clopidogrel Price Forecast indicates a potential moderate recovery in the upcoming quarter, supported by scheduled production turnarounds and improved retail demand.
• Clopidogrel Price Index Volatility reflected changes in crude oil-linked feedstocks and domestic logistics costs, shaping short-term sentiment.
• Export and Import Flow Adjustments influenced supply distribution, occasionally tightening availability in certain states and supporting marginal price stabilization.
Europe
• Clopidogrel Price Index weakened slightly during the quarter amid steady supply inflows from regional and overseas producers, alongside mild demand contraction from formulators.
• Average Clopidogrel Price remained under pressure as distributors adjusted inventory levels following lower-than-expected pharmaceutical offtake in major EU markets.
• Clopidogrel Spot Price displayed mixed sentiment, with southern European markets facing weaker demand while central regions observed modest restocking.
• Clopidogrel Production Cost Trend was aided by lower raw material prices, although high utility and energy expenses continued to constrain margin recovery.
• Clopidogrel Demand Outlook suggested cautious optimism ahead, with hospitals and drug manufacturers planning moderate restocking before the winter season.
• Clopidogrel Price Forecast anticipates stable-to-firm pricing in the near term, supported by seasonal demand recovery and balanced production schedules.
• Clopidogrel Price Index Volatility was shaped by exchange rate fluctuations (EUR vs. USD) and varying freight conditions across intra-EU trade routes.
• Export Market Sentiment stayed mixed, as stronger Asian competition limited outbound sales while localized shortages lent some domestic price support.
